Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) EBT (2023 - 2025)

Historic EBT for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$55.8 million.

  • Nuvation Bio's EBT fell 3538.46% to -$55.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$217.5 million, marking a year-over-year increase of 5914.19%. This contributed to the annual value of -$567.9 million for FY2024, which is 64924.01% down from last year.
  • Nuvation Bio's EBT amounted to -$55.8 million in Q3 2025, which was down 3538.46% from -$59.0 million recorded in Q2 2025.
  • In the past 5 years, Nuvation Bio's EBT ranged from a high of -$13.8 million in Q4 2023 and a low of -$462.5 million during Q2 2024
  • In the last 3 years, Nuvation Bio's EBT had a median value of -$41.2 million in 2024 and averaged -$73.8 million.
  • As far as peak fluctuations go, Nuvation Bio's EBT crashed by 214075.58% in 2024, and later soared by 8724.15% in 2025.
  • Over the past 3 years, Nuvation Bio's EBT (Quarter) stood at -$13.8 million in 2023, then tumbled by 258.63% to -$49.4 million in 2024, then decreased by 12.84% to -$55.8 million in 2025.
  • Its EBT stands at -$55.8 million for Q3 2025, versus -$59.0 million for Q2 2025 and -$53.2 million for Q1 2025.